openPR Logo
Press release

Latest 2021 report on Peptides and Heparin Market Size, Share, Application With Growth and Business Strategies Forecast

01-22-2021 11:30 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Peptides and Heparin Market

Peptides and Heparin Market

According to Fact.MR, the global peptide and heparin market is projected to reflect a high single-digit CAGR throughout the forecast period (2017-2026). The peptide and heparin market is estimated to reach nearly US$ 35,000 Mn revenues by 2026-end.

Request a report sample to gain comprehensive market insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=378

Vendors of Peptide Therapeutics are Outsourcing Manufacturing Processes to Developing Countries
Although therapeutic peptides were originally developed for replacing their endogenous lack, spectrum of the candidate peptide drugs available is not by far restrained to human peptide pool. With the help of multifarious organisms, bioactive peptides are being discovered through modern tools of peptidomics. A virtually infinite range of potential peptide-based medications await pharmacological characterization. Meanwhile, several methods of peptide synthesis are evolving to enable highly efficient production of extraordinarily long & heavily-modified compounds. Numerous clinical trials associated with peptide drug candidates are currently being conducted, which in turn represents a bright future for peptide-based therapeutics. Vendors of peptide therapeutics have been moving to developing countries on the back of large population base serving as potential clinical subjects. Lenient regulatory guidelines, skilled labor, low manufacturing costs, and low market competition are primary reasons why vendors of peptide therapeutics are outsourcing their manufacturing processes to these countries.

For information on the Research Approach used in the Report, Request Methodology@ https://www.factmr.com/connectus/sample?flag=RM&rep_id=378

The market for heparin will continue to be influenced by increasing prevalence of diseases, which lead to formation of clots. Concerns regarding adulteration had been the cause for the prohibition of bovine heparin by the U.S. FDA. However, extreme shortage of porcine heparin has led the FDA to reconsider introduction of bovine heparin, which in turn has led to a rise in amount of crude heparin. Heparin is increasingly used prior to surgeries, during blood transfusion or dialysis, when blood is collected as a sample, which implies their general use for reducing the blood clotting risk. Apart from surgical applications, heparin is also prescribed for preventing blood clot in patients affected with chest pain or angina. Heparin’s supply chain commences at slaughterhouses, trailed by various workshops that extract basic heparin material, called heparin crude, from the mucous membrane of pig intestine. Heparin crude is then sold to pharmaceutical companies, which post-processing produce heparin.

6 Key Future Prospects of Peptide and Heparin Market for Forecast Period 2017-2026

• Hospital pharmacies are expected to remain the dominant distribution channel for peptide and heparin. Revenues from sales of peptide and heparin in hospital pharmacies are anticipated to remain considerably larger than those from retail pharmacies and online pharmacies combined.
• On the basis of indication, revenues from sales of peptide and heparin for cancer treatment are projected to account for the largest market share by 2026-end. Cardiovascular and metabolic disorder indication will also remain remunerative in the market. Sales of peptide and heparin for central nervous systems indication are expected to register the fastest expansion through 2026.
• Oral route of administration will remain preferred for peptide and heparin, with revenues estimated to surpass US$ 15,000 Mn by 2026-end. However, sales of peptide and heparin with intravenous route of administration will register a comparatively faster growth through 2026.

Get Full Access of the Report @ https://www.factmr.com/checkout/378/S

• Liraglutide is expected to remain the most lucrative product in the market, followed by bortezomib and goserelin. Liraglutide sales will exhibit the highest CAGR through 2026. In addition, sales of sodium heparin, lithium heparin and exenatide are projected to register a parallel growth through 2026.
• Asia-Pacific excluding Japan (APEJ) will continue to be the largest market for peptide and heparin, in terms of revenues. The markets in Europe and North America will also remain lucrative, however revenues from these regions will remain significantly lower than those from APEJ.
• Key market participants identified by the report include Eli Lilly, Novo Nordisk, Sanofi, Takeda, Teva, Leo Pharma, Aspen, Pfizer Inc., Abbott Laboratories, Bachem, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., AmbioPharm, Inc., Hemmo Pharma, Biofer S.p.A, Celsus, and Baxter.

Unit No: AU-01-H
Gold Tower (AU)
Plot No: JLT-PH1-I3A
Jumeirah Lakes Towers, Dubai
United Arab Emirates
Contact: +353-1-6111-593
E-mail: sales@factmr.com
Website : https://www.factmr.com

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports.
We believe transformative intelligence can educate and inspire businesses to make smarter decisions.
We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Latest 2021 report on Peptides and Heparin Market Size, Share, Application With Growth and Business Strategies Forecast here

News-ID: 2229619 • Views: 301

More Releases from Fact.MR

Europe and North America, contributing around 70% of the Global Baby Care Produc …
The global baby care products market is projected to be valued at over US$ 8 billion in 2020, and is anticipated to surpass nearly US$ 19 billion by 2030. The spread of COVID-19 has brought a decline in demand for some baby care products, due to customer preference of spending on more important daily consumer products. Likewise, declining requests from institutional buyers such as hospitals, baby day care centers, etc., is causing
Rising Popularity of Fishing Activities in North America and Europe, Demand for …
The spread of COVID-19 is resulting in declining sales as most anglers are staying indoors. To overcome this situation, manufacturers are utilizing digital technologies and engaging customers via online portals. As such, the outbreak of this pandemic has shifted consumer focus to e-Commerce platforms. This, in turn, will strengthen demand for fishing lures over the forecast period. There has been significant growth in the number of anglers across the world, which has consequently
Regional Outlook of Vehicle Mounted Spotlights Market | Whelen Engineering Compa …
The global vehicle mounted spotlights market is set to observe a sizeable growth rate of over 4% in the coming decade. In the past years, this market grew at a modest pace of 3.5%, owing to declining demand from the automobile industry. However, advancements in technology and adoption of LED-based vehicle mounted spotlights have augmented market growth. In the coming decade, widespread adoption of wireless control vehicle mounted spotlights by leveraging manufacturing
Lifesciences Enterprise Storage Market Size to Witness Sustained Growth through …
Increasing difficulties arising in management and loading of clinical data from lifescience enterprises has propelled the need for adopting effective storage solutions. Leading players in the healthcare-IT industry are introducing effective lifesciences enterprise storage solutions to capture these concerns. Moreover, several lifesciences organizations are adopting cloud-based storage models to share data securely and effectively across multiple landscapes in the healthcare industry. However, growing concerns over the safety of these lifesciences enterprise storage

All 5 Releases


More Releases for Heparin

Global Heparin(Heparin Sodium and Heparin Calcium) Market drivers, restraints, g …
Latest industry research report on: Global Heparin(Heparin Sodium and Heparin Calcium) Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts This report studies the global Heparin(Heparin Sodium and Heparin Calcium) market status and forecast, categorizes the global Heparin(Heparin Sodium and Heparin Calcium) market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China,
Global Heparin(Heparin Sodium and Heparin Calcium) Market Professional Survey Re …
"The Report Global Heparin(Heparin Sodium and Heparin Calcium) Market Professional Survey Report 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" This report studies Heparin(Heparin Sodium and Heparin Calcium) in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report
10-11-2017 | Health & Medicine
TMR
Heparin Market – Global Industry Analysis 2016
The heparin market in Europe is rather consolidated, with the Sanofi, Aspen, Pfizer, and Leo Pharma accounting for over 65% of the market in 2015. In a new study, Transparency Market Research (TMR) has found that Sanofi is the clear leader in the Europe heparin market, enjoying a 47.5% share in 2015. Increased global sales of Lovenox can be attributed to the company’s success.   “A focus on the expansion of R&D activities, in-licensing
Heparin Market: Professional and Technical Industry Insights
Global Heparin Market: Key Trends  The prevalence of coagulation disorders such as venous thromboembolism (VTE), deep vein thrombosis (DVT), and pulmonary embolism (PE) has remarkably increased in both Europe and North America. Since heparin is one of the foremost clinical anticoagulants, the rising incidence of coagulation disorders will in turn fuel demand for heparin products, finds Transparency Market Research (TMR). Currently, heparin manufacturers are focusing on the development of generic versions
07-18-2017 | Health & Medicine
Heparin
2014 - 2022: Qualitative And Quantitative Analysis Of Heparin Market In Europe B …
Researchmoz added Most up-to-date research on "2014 - 2022: Qualitative And Quantitative Analysis Of Heparin Market In Europe By Product Such As Unfractionated Heparin, Low Molecular Weight Heparin & Ultra Low Molecular Weight Heparin" to its huge collection of research reports. This report provides in-depth analysis of the heparin market in Europe. Stakeholders for this report include manufacturers of heparin products, crude heparin suppliers, heparin processing companies, and new players planning
Europe Heparin Sodium Market Research Report 2017
Report Hive market Research Released a New Research Report of 144 pages on Title "Europe Heparin Sodium Market Research Report 2017"with detailed Analysis, Forecast and Strategies. The Europe Heparin Sodium Market Research Report 2017 is a professional and in-depth study on the current state of the heparin sodium market. Annual estimates and forecasts are provided for the period 2017 through 2023. Also, a six-year historic analysis is provided for these markets.